These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 39153092)
1. Navigating glioblastoma complexity: the interplay of neurotransmitters and chromatin. Romero-Reyes J; Vázquez-Martínez ER; Silva CC; Molina-Hernández A; Díaz NF; Camacho-Arroyo I Mol Biol Rep; 2024 Aug; 51(1):912. PubMed ID: 39153092 [TBL] [Abstract][Full Text] [Related]
2. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma. Biserova K; Jakovlevs A; Uljanovs R; Strumfa I Cells; 2021 Mar; 10(3):. PubMed ID: 33799798 [TBL] [Abstract][Full Text] [Related]
3. Chromatin remodeler HELLS maintains glioma stem cells through E2F3 and MYC. Zhang G; Dong Z; Prager BC; Kim LJ; Wu Q; Gimple RC; Wang X; Bao S; Hamerlik P; Rich JN JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30779712 [TBL] [Abstract][Full Text] [Related]
4. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness. Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419 [TBL] [Abstract][Full Text] [Related]
5. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Gao X; Jin W Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866 [TBL] [Abstract][Full Text] [Related]
6. Differences among brain tumor stem cell types and fetal neural stem cells in focal regions of histone modifications and DNA methylation, broad regions of modifications, and bivalent promoters. Yoo S; Bieda MC BMC Genomics; 2014 Aug; 15(1):724. PubMed ID: 25163646 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation of cancer stem cell and tumorigenesis. Zhu K; Xie V; Huang S Adv Cancer Res; 2020; 148():1-26. PubMed ID: 32723561 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic modulation of metabolism in glioblastoma. Dong Z; Cui H Semin Cancer Biol; 2019 Aug; 57():45-51. PubMed ID: 30205139 [TBL] [Abstract][Full Text] [Related]
10. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells. Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630 [TBL] [Abstract][Full Text] [Related]
12. The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma. Kijewska M; Kocyk M; Kloss M; Stepniak K; Korwek Z; Polakowska R; Dabrowski M; Gieryng A; Wojtas B; Ciechomska IA; Kaminska B Oncotarget; 2017 Mar; 8(10):16340-16355. PubMed ID: 28030801 [TBL] [Abstract][Full Text] [Related]
13. The landscape of the mesenchymal signature in brain tumours. Behnan J; Finocchiaro G; Hanna G Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477 [TBL] [Abstract][Full Text] [Related]
14. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma. Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055 [TBL] [Abstract][Full Text] [Related]
15. Metabolic heterogeneity and adaptability in brain tumors. Badr CE; Silver DJ; Siebzehnrubl FA; Deleyrolle LP Cell Mol Life Sci; 2020 Dec; 77(24):5101-5119. PubMed ID: 32506168 [TBL] [Abstract][Full Text] [Related]
16. Monoamines in glioblastoma: complex biology with therapeutic potential. Caragher SP; Hall RR; Ahsan R; Ahmed AU Neuro Oncol; 2018 Jul; 20(8):1014-1025. PubMed ID: 29126252 [TBL] [Abstract][Full Text] [Related]
17. The role of octamer binding transcription factors in glioblastoma multiforme. Rooj AK; Bronisz A; Godlewski J Biochim Biophys Acta; 2016 Jun; 1859(6):805-11. PubMed ID: 26968235 [TBL] [Abstract][Full Text] [Related]
18. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties. Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554 [TBL] [Abstract][Full Text] [Related]
19. Glioma stem cell maintenance: the role of the microenvironment. Heddleston JM; Hitomi M; Venere M; Flavahan WA; Yang K; Kim Y; Minhas S; Rich JN; Hjelmeland AB Curr Pharm Des; 2011; 17(23):2386-401. PubMed ID: 21827414 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional control of brain tumor stem cells by a carbohydrate binding protein. Sharanek A; Burban A; Hernandez-Corchado A; Madrigal A; Fatakdawala I; Najafabadi HS; Soleimani VD; Jahani-Asl A Cell Rep; 2021 Aug; 36(9):109647. PubMed ID: 34469737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]